Showing results (2471-2480 of 2,892) with videos related to

Sort By:
Pageof 290
Head & Neck|February 14, 2019
Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profilingSaad A Khan, Bo Ci, Yang Xie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2025
Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastasesJ A Wilcox, M Y Jeng, S Tischfield, et al.
Circulation Research|March 9, 2002
Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failureShaw-Yung Shai, Alice E Harpf, Christopher J Babbitt, et al.
Oncotarget|May 24, 2016
Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinomaMonika Joshi, Monali Vasekar, Petros Grivas, et al.
Gastroenterology|April 12, 2016
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel DiseaseRona Yaeger, Manish A Shah, Vincent A Miller, et al.
JAMA Network Open|August 17, 2022
Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical PracticeSanket S Dhruva, Shumin Zhang, Jiajing Chen, et al.
Circulation|July 6, 2006
Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgeryJeremiah R Brown, Richard P Cochran, Lawrence J Dacey, et al.
Science (New York, N.Y.)|September 29, 2018
Predicting global killer whale population collapse from PCB pollutionJean-Pierre Desforges, Ailsa Hall, Bernie McConnell, et al.
The Oncologist|March 23, 2026
Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision TherapyChiara Mercinelli, Dean Pavlick, Neeraj Agarwal, et al.
The Oncologist|March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A AlterationJulia A Elvin, Laurie M Gay, Rita Ort, et al.
Pageof 290